» Articles » PMID: 32671630

Glutamine Metabolism in Th17/Treg Cell Fate: Applications in Th17 Cell-associated Diseases

Overview
Specialties Biology
Science
Date 2020 Jul 17
PMID 32671630
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Alteration in the Th17/Treg cell balance is implicated in various autoimmune diseases and these disease-associated pathologies. Increasing investigations have shown that glutamine metabolism regulates the differentiation of Th17 and Treg cells. Here we summarize the mechanisms by which glutamine metabolism regulates Th17/Treg cell fate. Some examples of a glutamine metabolism-dependent modulation of the development and progression of several Th17 Treg cell-associated diseases are provided afterward. This review will provide a comprehensive understanding of the importance of glutamine metabolism in the fate of Th17 Treg cell differentiation.

Citing Articles

Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?.

Kim J, Li J, Wei J, Lim S Immune Netw. 2025; 25(1):e13.

PMID: 40078783 PMC: 11896657. DOI: 10.4110/in.2025.25.e13.


Influence of Foliar Application of Nanoparticles on Low Temperature Resistance of Rice Seedlings.

Ullah S, Ikram M, Xiao J, Khan A, Din I, Huang J Plants (Basel). 2024; 13(21).

PMID: 39519868 PMC: 11548232. DOI: 10.3390/plants13212949.


The role of Th/Treg immune cells in osteoarthritis.

Wen Z, Qiu L, Ye Z, Tan X, Xu X, Lu M Front Immunol. 2024; 15:1393418.

PMID: 39364408 PMC: 11446774. DOI: 10.3389/fimmu.2024.1393418.


Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease.

Miguel V, Shaw I, Kramann R Nat Rev Nephrol. 2024; 21(1):39-56.

PMID: 39289568 DOI: 10.1038/s41581-024-00889-z.


The immune landscape of the inflamed joint defined by spectral flow cytometry.

Attrill M, Shinko D, Alexiou V, Kartawinata M, Wedderburn L, Pesenacker A Clin Exp Immunol. 2024; 218(3):221-241.

PMID: 39101538 PMC: 11557149. DOI: 10.1093/cei/uxae071.


References
1.
Alberghina L, Gaglio D . Redox control of glutamine utilization in cancer. Cell Death Dis. 2014; 5:e1561. PMC: 4454159. DOI: 10.1038/cddis.2014.513. View

2.
Almeida L, Lochner M, Berod L, Sparwasser T . Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. 2016; 28(5):514-524. DOI: 10.1016/j.smim.2016.10.009. View

3.
Altman B, Stine Z, Dang C . From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2017; 16(11):749. DOI: 10.1038/nrc.2016.114. View

4.
Angelin A, Gil-de-Gomez L, Dahiya S, Jiao J, Guo L, Levine M . Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 2017; 25(6):1282-1293.e7. PMC: 5462872. DOI: 10.1016/j.cmet.2016.12.018. View

5.
Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M . Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. Elife. 2017; 6. PMC: 5257256. DOI: 10.7554/eLife.21330. View